SCD and ovarian cancer: Inhibition of SCD1 using a small molecule inhibitor or siRNA significantly reduced lipid unsaturation levels in ovarian cancer spheroids and then suppressed sphere-forming ability with decreased levels of ALDH1A1, Nanog, Sox2, and Oct-4 mRNA expression [15].